Home › USFDA Tracker › Syngene International

Syngene International — USFDA Status

Inspections, Form 483 observations, OAI classifications, warning letters, import alerts and approvals for Syngene International (NSE: SYNGENE, BSE: 539268), from US FDA records and exchange filings.

90
Compliance score (5 years) · how
3
USFDA-inspected plants on record
0
OAI classifications (5y)
0
Form 483s on record (5y)
0
Open warning letters
Latest USFDA record: USFDA inspection classified VAI — 20 Feb 2025 (Bengaluru plant). Source: FDA Data Dashboard.
USFDA events by year
2022
2023
2025
NAIVAIForm 483OAIWarning letterImport alertUS approval

Plants

PlantFEILatest resultLast inspectionHistory (newest first)
Bengaluru
Syngene International Ltd.
3003600340 VAI 20 Feb 2025
Dakshina Kannada, Mangalore
Syngene International Limited
3012608389 NAI 26 May 2023
Bengalore
Syngene International Limited
3007907068 NAI 28 Oct 2022

Full USFDA timeline

20 Feb 2025
VAI — minor issues
USFDA inspection classified VAI
Bengaluru · FEI 3003600340 · Syngene International Ltd., Bengaluru — Monitoring of Marketed Animal Drugs, Feed, and Devices (Veterinary)
26 May 2023
NAI — clean
USFDA inspection classified NAI
Dakshina Kannada, Mangalore · FEI 3012608389 · Syngene International Limited, Dakshina Kannada, Mangalore — Drug Quality Assurance (Drugs)
15 Nov 2022
NAI — clean
USFDA inspection classified NAI
Bengaluru · FEI 3003600340 · Syngene International Ltd., Bengaluru — Pre-Approval Eval. of Animal Drugs and Food Additives (Veterinary)
28 Oct 2022
NAI — clean
USFDA inspection classified NAI
Bengalore · FEI 3007907068 · Syngene International Limited, Bengalore — Bioresearch Monitoring (Drugs)
📎 Cite this data: Source: PharmaRoz analysis of FDA inspection data and exchange filings, updated 12 Nov 2026 — https://pharmaroz.com/company/syngene